Developing new methods to create important sulfur-containing compounds for medicine
New organosulfur-based strategies for efficient construction of carbon-carbon and carbon-heteroatom bonds
['FUNDING_OTHER'] · UNIVERSITY OF TEXAS SAN ANTONIO · NIH-11116866
This study is looking for better ways to create important ingredients used in many medicines, which could lead to new and improved treatments for patients.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS SAN ANTONIO (nih funded) |
| Locations | 1 site (SAN ANTONIO, UNITED STATES) |
| Trial ID | NIH-11116866 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the synthesis of organosulfur compounds, which are crucial for many medications. By exploring new strategies for constructing carbon-carbon and carbon-heteroatom bonds, the project aims to enhance the efficiency and selectivity of these chemical processes. Patients may benefit from advancements in drug discovery and the development of new therapeutic agents that utilize these compounds. The research will involve innovative chemical methodologies to overcome existing challenges in medicinal chemistry.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with conditions that could be treated by new sulfur-based drugs or those involved in drug development.
Not a fit: Patients who are not seeking new treatments or those with conditions unrelated to the therapeutic applications of organosulfur compounds may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective and targeted medications for various health conditions.
How similar studies have performed: Previous research has shown promise in the development of organosulfur compounds, indicating that this approach has potential for success.
Where this research is happening
SAN ANTONIO, UNITED STATES
- UNIVERSITY OF TEXAS SAN ANTONIO — SAN ANTONIO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LARIONOV, OLEG V — UNIVERSITY OF TEXAS SAN ANTONIO
- Study coordinator: LARIONOV, OLEG V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.